Immatics NV (IMTX)
10.01
+0.23
(+2.35%)
USD |
NASDAQ |
Apr 26, 16:00
9.99
-0.02
(-0.20%)
After-Hours: 20:00
Immatics Revenue (TTM): 58.49M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.49M |
| September 30, 2023 | 79.84M |
| June 30, 2023 | 88.56M |
| March 31, 2023 | 82.53M |
| December 31, 2022 | 187.48M |
| September 30, 2022 | 166.97M |
| June 30, 2022 | 159.39M |
| March 31, 2022 | 147.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 40.76M |
| September 30, 2021 | 34.03M |
| June 30, 2021 | 35.64M |
| March 31, 2021 | 36.98M |
| December 31, 2020 | 35.83M |
| September 30, 2020 | 29.42M |
| June 30, 2020 | 25.84M |
| March 31, 2020 | 24.29M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
24.29M
Minimum
Mar 2020
187.48M
Maximum
Dec 2022
77.09M
Average
49.63M
Median
Revenue (TTM) Benchmarks
| MorphoSys AG | 257.99M |
| Affimed NV | 8.941M |
| InflaRx NV | -- |
| BioNTech SE | 4.122B |
| CureVac NV | 45.82M |